Contact
searchSearch
HMP Global

News

News
Dupilumab Significantly Increases Itch- and Hive-Free Days in Chronic Spontaneous Urticaria
04/01/2026
Riya Gandhi, MA
Phase 3 data show more than 19 additional symptom-free days with dupilumab vs placebo over 24 weeks.
Phase 3 data show more than 19 additional symptom-free days with dupilumab vs placebo over 24 weeks.
Phase 3 data show more than 19...
04/01/2026
The Dermatologist
News
Zasocitinib Shows Rapid Onset of Action Linked to TYK2 Pathway Modulation in Plaque Psoriasis
04/01/2026
Riya Gandhi, MA
Phase 2b data reveal early biomarker changes correlating with clinical improvement as early as week 4.
Phase 2b data reveal early biomarker changes correlating with clinical improvement as early as week 4.
Phase 2b data reveal early...
04/01/2026
The Dermatologist
News
Tildrakizumab Improves Nail Psoriasis Severity and Pain With Sustained Efficacy Through 52 Weeks
04/01/2026
Riya Gandhi, MA
Phase 3b trial shows meaningful improvements in nail outcomes and pain, with durable responses and consistent safety.
Phase 3b trial shows meaningful improvements in nail outcomes and pain, with durable responses and consistent safety.
Phase 3b trial shows meaningful...
04/01/2026
The Dermatologist
News
Tralokinumab Demonstrates Sustained Real-World Effectiveness in Patients With Skin of Color and Atopic Dermatitis
04/01/2026
Riya Gandhi, MA
TRACE study data show consistent improvements in disease severity and quality of life over 12 months in an underrepresented population.
TRACE study data show consistent improvements in disease severity and quality of life over 12 months in an underrepresented population.
TRACE study data show consistent...
04/01/2026
The Dermatologist
News
Roflumilast Cream 0.05% Provides Sustained Improvements in Quality of Life and Family Impact in Pediatric Atopic Dermatitis
04/01/2026
Riya Gandhi, MA
Long-term extension data show durable caregiver-reported benefits and symptom control through 56 weeks in children aged 2 to 5 years.
Long-term extension data show durable caregiver-reported benefits and symptom control through 56 weeks in children aged 2 to 5 years.
Long-term extension data show...
04/01/2026
The Dermatologist
News
Risankizumab Significantly Improves Quality of Life in Genital and Scalp Psoriasis at 16 Weeks
04/01/2026
Riya Gandhi, MA
Phase 4 trial shows most patients achieve minimal or no quality-of-life impact, highlighting benefits in high-burden psoriasis areas.
Phase 4 trial shows most patients achieve minimal or no quality-of-life impact, highlighting benefits in high-burden psoriasis areas.
Phase 4 trial shows most...
04/01/2026
The Dermatologist
News
Rezpegaldesleukin Shows Promising Efficacy Across Disease Severity in Atopic Dermatitis Phase 2b Trial
04/01/2026
Riya Gandhi, MA
Novel Treg-targeting biologic demonstrates significant improvements in EASI and itch with consistent responses across subgroups.
Novel Treg-targeting biologic demonstrates significant improvements in EASI and itch with consistent responses across subgroups.
Novel Treg-targeting biologic...
04/01/2026
The Dermatologist
News
Delgocitinib Cream Demonstrates Consistent Efficacy in Chronic Hand Eczema Regardless of Prior Systemic Therapy
04/01/2026
Riya Gandhi, MA
Phase 3 pooled analysis shows significant improvements in disease severity, itch, and pain across both systemic-naïve and experienced patients.
Phase 3 pooled analysis shows significant improvements in disease severity, itch, and pain across both systemic-naïve and experienced patients.
Phase 3 pooled analysis shows...
04/01/2026
The Dermatologist
News
Tildrakizumab Improves Burdensome Symptoms and Psychological Well-Being Beyond Skin Clearance in Psoriasis
04/01/2026
Riya Gandhi, MA
Real-world 2-year data show sustained reductions in itch, pain, fatigue, and significant gains in mental well-being.
Real-world 2-year data show sustained reductions in itch, pain, fatigue, and significant gains in mental well-being.
Real-world 2-year data show...
04/01/2026
The Dermatologist
News
Tildrakizumab Delivers Sustained Skin Clearance and High-Impact Area Control Over 2 Years in Real-World Psoriasis Study
04/01/2026
Riya Gandhi, MA
POSITIVE study data show durable PASI responses and significant improvements in scalp, palmoplantar, and nail psoriasis.
POSITIVE study data show durable PASI responses and significant improvements in scalp, palmoplantar, and nail psoriasis.
POSITIVE study data show durable...
04/01/2026
The Dermatologist

Popular Articles

Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
Joel M. Gelfand, MD, MSCE
Conference Coverage
Hot Topics in Dermatology
05/08/2024
Jessica Garlewicz
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
The session aimed to delve into...
05/08/2024
The Dermatologist
Atopic dermatitis
News
Arcutis Presents Long-Term Data on Roflumilast Cream for Atopic Dermatitis
06/11/2024
Riya Gandhi, MA
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia...
06/11/2024
The Dermatologist
psoriatic arthritis
News
Vaccination Recommendations for Patients Receiving Antipsoriatic Systemic Therapies
07/26/2024
Jessica Garlewicz
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate...
07/26/2024
The Dermatologist
Cover Story
Navigating Women’s Health Dermatology Through Life’s Stages
09/06/2024
Jennifer Foster, BS; Melissa Mauskar, MD
By addressing specific needs at each stage, dermatologists can provide comprehensive and empathetic care, enhancing both the health and confidence of their patients.
By addressing specific needs at each stage, dermatologists can provide comprehensive and empathetic care, enhancing both the health and confidence of their patients.
By addressing specific needs at...
09/06/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use